CoChat

Bioreactor design for clinical‐grade expansion of stem cells

dos Santos, Francisco F., Andrade, Pedro Z., da Silva, Cláudia Lobato, Cabral, Joaquim M.S. · 2013 · Biotechnology Journal
Cited by 105

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The many clinical trials currently in progress will likely lead to the widespread use of stem cell‐based therapies for an extensive variety of diseases, either in autologous or allogeneic settings. With the current pace of progress, in a few years' time, the field of stem cell‐based therapy should be able to respond to the market demand for safe, robust and clinically efficient stem cell‐based therapeutics. Due to the limited number of stem cells that can be obtained from a single donor, one of the major challenges on the roadmap for regulatory approval of such medicinal products is the expansion of stem cells using Good Manufacturing Practices (GMP)‐compliant culture systems. In fact, manufacturing costs, which include production and quality control procedures, may be the main hurdle for developing cost‐effective stem cell therapies. Bioreactors provide a viable alternative to the traditional static culture systems in that bioreactors provide the required scalability, incorporate monitoring and control tools, and possess the operational flexibility to be adapted to the differing requirements imposed by various clinical applications. Bioreactor systems face a number of issues when incorporated into stem cell expansion protocols, both during development at the research level and when bioreactors are used in on‐going clinical trials. This review provides an overview of the issues that must be confronted during the development of GMP‐compliant bioreactors systems used to support the various clinical applications employing stem cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biot.201200373

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 105

Metadata

Authors
dos Santos, F. F., Andrade, P. Z., da Silva, C. L., & Cabral, J. M. S.
Venue
Biotechnology Journal
Publisher
Wiley
Published
2013-04-26
Volume
8
Issue
6
Pages
644-654
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W2158733788
Cited by
105
References
4
FWCI
4.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioreactor design for clinical‐grade expansion of stem cells. https://app.cochat.ai/papers/10.1002/biot.201200373
The paper
dos Santos, F. F., Andrade, P. Z., da Silva, C. L., & Cabral, J. M. S. (2013). Bioreactor design for clinical‐grade expansion of stem cells. Biotechnology Journal. https://doi.org/10.1002/biot.201200373

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.